They address our emerging idea of the immune response to this new coronavirus, prospective buyers for vaccine progress, immunopathology of COVID-19 and how it might be handled with immunomodulatory drugs. Type III hypersensitivity reactions manifest when IgG and IgM antibodies bind to soluble proteins (rather then mobile floor molecules as https://directivepublications.org/journal-of-immunology/